Suppr超能文献

我们能否采用血清腱生蛋白-C检测来确定主动脉瘤和主动脉夹层的预后?

Could we adopt serum Tenascin-C assays to determine prognosis in aortic aneurysms and dissections?

作者信息

Santos Larissa Cristina França, de Paiva Mylenne Alinne Falcão, Santana Matheus Valois Lapa, Mendes Rodrigo, Tenório Pedro Pereira

机构信息

Universidade Federal do Vale do São Francisco - UNIVASF, Paulo Afonso, BA, Brasil.

Universidade Federal de São Paulo - UNIFESP, São Paulo, SP, Brasil.

出版信息

J Vasc Bras. 2021 Aug 13;20:e20200165. doi: 10.1590/1677-5449.200165. eCollection 2021.

Abstract

Abdominal aortic aneurysm is an abnormal dilatation, while acute aortic dissection is a delamination of the tunica media, forming a false lumen. Tenascin-C is a glycoprotein that can be found in situations involving tissue damage. The objective of this article is to evaluate whether Tenascin-C assays could be of use for predicting prognosis in abdominal aortic aneurysms and acute aortic dissection. We conducted an integrative literature review, for which four articles were considered eligible. Two of these studies associated higher Tenascin-C levels with protective factors and lower risk of injury, whereas the other two correlated them with worse prognosis. Some authors believe that Tenascin-C could be a candidate biomarker, but these studies are still inconclusive with regard to its role in the clinical outcomes of patients with aneurysms.

摘要

腹主动脉瘤是一种异常扩张,而急性主动脉夹层是中膜的分层,形成假腔。腱生蛋白-C是一种糖蛋白,可在涉及组织损伤的情况下发现。本文的目的是评估腱生蛋白-C检测是否可用于预测腹主动脉瘤和急性主动脉夹层的预后。我们进行了一项综合文献综述,其中有四篇文章被认为符合要求。其中两项研究将较高的腱生蛋白-C水平与保护因素和较低的损伤风险相关联,而另外两项研究则将它们与较差的预后相关联。一些作者认为腱生蛋白-C可能是一种候选生物标志物,但这些研究在其在动脉瘤患者临床结局中的作用方面仍无定论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796f/8366403/bc902d3f5998/jvb-20-e20200165-g01-en.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验